MCL1 and leukemia: It is noteworthy that VEN enhances T cell-mediated antileukemic activity by increasing ROS production [121] and that MCL1 targeting can modulate leukemia cell metabolism, cell adhesion proteins, and leukemia–stromal interactions [122].